Psyomics secures £2.4m in new funding to continue expansion of mental health platform within the NHS
UK-based healthtech company Psyomics has closed a £2.4m funding round as they continue to expand access to their online mental health assessment platform to individual users and NHS trusts. The financing was led by Parkwalk, the UK’s most active investor in the university spin-out sector. Meltwind and other investors also participated, along with new investment from Newable Ventures.
Optibrium receives further investment from Kester Capital
Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Entries now open for the 2022 Deloitte UK Technology Fast 50 awards
Now in its 25th year, the awards recognise and rank the 50 fastest growing technology companies in the UK; Last year’s winner ClearBank achieved a three-year growth rate of 21,569% to the year 2020/21; The average three-year growth rate recorded for companies in the Deloitte UK Technology Fast 50 was 3,337% in 2020/21; Last year’s Fast 50 companies generated combined revenues of £2.92…
Nuffield Health - let’s talk glue ear in children
As the only private hospital in the area that can see children of all ages, from little ones to under-18s, Nuffield Health Cambridge Hospital presents a free virtual event for anyone who would like to know more about glue ear in children.
Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment
Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).
Early diagnosis of Cancer - myth or reality?
Early diagnosis of cancer - myth or reality?
‘Keep your cool’ – advice for men wanting to be fathers
There are many ways to improve sperm health, advises specialist in male fertility ahead of Father’s Day .
Medovate secures HSA approval in Singapore for game-changing SAFIRA® system
Medovate and its Singapore-based distributor Bluestone Corporation Pte Ltd announces they have secured Singapore’s Health Sciences Authority (HSA) approval for the game-changing SAFIRA® (SAFer Injection for Regional Anaesthesia) system.
The elephant in the room: addressing device development challenges early on
Andrea Pybus says: I’ve often heard colleagues say that it would be the ‘challenge we didn’t anticipate, that catches us out’. I have certainly experienced this. But more often than not, the challenges or ‘project killers’ I have witnessed were identified early in the medical device programme. In this blog I discuss the reasons why unanswered questions asked at the start of a project can get…
Four steps to selecting the right device to deliver therapies
Charlotte Harris, Head of Front End Innovation at Team Consulting, discusses four steps that have to be taken when selecting the right drug delivery device for your chosen therapy.
See you in Vegas?
The Marcus Evans Medical Device Manufacturing and R&D Summit will be live in Las Vegas from the 23rd-24th of June and we can’t wait to see you there.
Arecor announces exclusive collaboration with a top 5 global pharmaceutical company
Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces that it has signed an exclusive formulation study collaboration with a top five global pharmaceutical company.
ARU researcher to conduct study into osteoarthritis
Dr Jasmine Samvelyan receives funding to investigate impact of osteoarthritis on the joints
Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies
Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.
seqWell appoints Dr Amy Liao to Board of Directors
Beverly, Mass – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…
Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer
Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.
Tackling the challenges of cloud connectivity
In a new article for ONdrugDelivery, Gabrielle Whitworth-Smith and Thomas Watts consider the various challenges of building cloud connectivity into your medical device platform.
How digital UX in clinical trials can improve measures
Implementing Digital health technologies effectively can be challenging. In a new article for ONdrugDelivery, Ben Cox, Head of Digital Design, discusses how adopting a UX approach when designing digital tools can lead to more meaningful measures.
Planning system helps fund GP surgery expansion
Nearly £90,000, secured from developers by South Cambridgeshire District Council, has been passed to the NHS to help fund an expansion of a GP surgery.
A new pioneering clinic launches to treat reversible form of dementia
Addenbrooke’s Hospital in Cambridge has launched a ground-breaking, multidisciplinary clinic to help identify and treat people with a frequently misunderstood condition called normal pressure hydrocephalus (NPH).
Evonetix appoints Colin McCracken as Chief Executive Officer
Cambridge, UK - EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, announces the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the Company’s development and the commercialisation of its semiconductor-based DNA synthesis platform.
Bio-Rad Launches Foresight Pro Columns for Biotherapeutic Production
Helcules, Calif. - Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological drug development and production.
Innovate UK awards grant to Orbit Discovery to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery
The project will use microfluidic technology to improve efficiency of peptide therapeutics discovery for challenging drug targets.
More lab space snapped up at The Epicentre, Haverhill
Five new dedicated laboratory spaces at The EpiCentre in Haverhill have been snapped up before completion, due to the rapid upsurge in demand for biotech and life sciences laboratories in the Cambridgeshire area.
2 years after Germany's regulation For digital health apps, what can we learn?
At the end of 2019, the Digital Healthcare Act (Digitales Versorgungsgesetz, DVG) introduced a dedicated pathway enabling reimbursement of digital health offerings in Germany, bringing more transparency into the approval process for manufacturers, physicians, and patients.